Symposium:               Metabolic Syndrome: From Clinical Insights to New Therapies

 

Track:                         Feeding, Fuel and Fat: Energy Metabolism

Monday, 3:15 PM—5:15 PM, 30 D/E

Sponsored by:             APS Liaison with Industry Committee

Chaired:                       Christine Schnackenberg and Chahrzad Montrose-Rafizadeh

 

3:15 PM                       Genetic and physiological insights into metabolic syndrome. Robert A. Hegele. Robarts Research Inst.

 

3:45 PM                       PPAR alpha/gamma activation for the treatment of dyslipidermia and insulin resistance. Nicholas D. Oakes. AstraZeneca.

 

4:15 PM                       Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes. Nancy A. Thornberry. Merck Res. Lab.

 

4:45 PM                       Role of sphingolipids in atherosclerosis and metabolic syndrome. Sotirios Karathanasis. Eli Lilly & Co.